Doyle Anthony Insider Trades

Insider Trading History

Track insider trading activity for Doyle Anthony. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $3.14M 380,328 shares
Last Trade
Dec 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.85M 250,100 shares
$7.39
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $3.12M 377,867 shares
Last Trade
Dec 19, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.2k 2,461 shares
$7.39
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $2.14M 259,628 shares
Last Trade
Dec 14, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.4k 7,890 shares
$7.53
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $2.2M 266,744 shares
Last Trade
May 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$202k 36,300 shares
$5.57
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $1.88M 227,444 shares
Last Trade
Dec 19, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15k 2,482 shares
$6.05
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $1.94M 235,401 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 158,500 shares
$6.43
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $1.9M 229,926 shares
Last Trade
Dec 14, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$35.2k 5,475 shares
$6.43
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $1.35M 163,966 shares
Last Trade
Dec 15, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.1k 5,700 shares
$10.90
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $1.72M 208,719 shares
Last Trade
Dec 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.19M 279,000 shares
$11.43
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $1.39M 168,719 shares
Last Trade
Dec 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$857k 75,000 shares
$11.43
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $773k 93,719 shares
Last Trade
Nov 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$440k 35,258 shares
$12.48
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $2.74M 332,500 shares
Last Trade
Dec 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.76M 332,500 shares
$8.31
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $446k 54,000 shares
Last Trade
Aug 11, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$220k 54,000 shares
$4.08
$8.25
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief Financial Officer
Holding Value $4.95M 600,000 shares
Last Trade
Apr 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.35M 600,000 shares
$3.91
$8.25

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up